FI952953A - Aineita metabolisten luustosairauksien hoitamiseen - Google Patents

Aineita metabolisten luustosairauksien hoitamiseen Download PDF

Info

Publication number
FI952953A
FI952953A FI952953A FI952953A FI952953A FI 952953 A FI952953 A FI 952953A FI 952953 A FI952953 A FI 952953A FI 952953 A FI952953 A FI 952953A FI 952953 A FI952953 A FI 952953A
Authority
FI
Finland
Prior art keywords
substances
treatment
skeletal disorders
metabolic
metabolic skeletal
Prior art date
Application number
FI952953A
Other languages
English (en)
Swedish (sv)
Other versions
FI952953A0 (fi
Inventor
Masakazu Katoh
Kazuyuki Kitamura
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of FI952953A0 publication Critical patent/FI952953A0/fi
Publication of FI952953A publication Critical patent/FI952953A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2006—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI952953A 1994-06-17 1995-06-15 Aineita metabolisten luustosairauksien hoitamiseen FI952953A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6135275A JPH083058A (ja) 1994-06-17 1994-06-17 新規な骨代謝疾患治療剤

Publications (2)

Publication Number Publication Date
FI952953A0 FI952953A0 (fi) 1995-06-15
FI952953A true FI952953A (fi) 1995-12-18

Family

ID=15147903

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952953A FI952953A (fi) 1994-06-17 1995-06-15 Aineita metabolisten luustosairauksien hoitamiseen

Country Status (10)

Country Link
US (1) US5726148A (fi)
EP (1) EP0687470A3 (fi)
JP (1) JPH083058A (fi)
KR (1) KR960000248A (fi)
AU (1) AU697136B2 (fi)
CA (1) CA2152023A1 (fi)
FI (1) FI952953A (fi)
HU (1) HU218947B (fi)
NO (1) NO952411L (fi)
TW (1) TW496740B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091181B2 (en) 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
US20020028798A1 (en) * 1995-12-12 2002-03-07 Omeros Medical Systems Irrigation solution and method for inhibition of pain and inflammation
US7029861B1 (en) 1998-09-15 2006-04-18 Board Of Regents, The University Of Texas System LPS-response gene compositions and methods
JP3755564B2 (ja) 1999-05-24 2006-03-15 株式会社村田製作所 圧電共振部品及びその製造方法
ATE399025T1 (de) 1999-07-21 2008-07-15 Omeros Corp Spüllösungen und verfahren zur schmerzhemmung, entzündungshemmung und hemmung des knorpelabbaus
WO2002066063A1 (fr) * 2001-02-23 2002-08-29 Nippon Organon K.K. Traitements de maladies osseuses metaboliques

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968607A (en) * 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
US5319071A (en) * 1987-11-25 1994-06-07 Immunex Corporation Soluble interleukin-1 receptors
WO1989004838A1 (en) * 1987-11-25 1989-06-01 Immunex Corporation Interleukin-1 receptors
WO1991000742A1 (en) * 1989-07-07 1991-01-24 E.I. Du Pont De Nemours And Company Soluble human b-cell interleukin-1 receptor
EP0474141B1 (en) * 1990-09-03 1996-01-31 Kuraray Co., Ltd. Peptide or its salts
EP0563239A4 (en) * 1990-12-20 1994-10-12 Univ Pittsburgh A truncated interleukin-1 receptor gene for the treatment of arthritis.

Also Published As

Publication number Publication date
KR960000248A (ko) 1996-01-25
HU218947B (hu) 2001-01-29
FI952953A0 (fi) 1995-06-15
EP0687470A2 (en) 1995-12-20
US5726148A (en) 1998-03-10
HUT72054A (en) 1996-03-28
AU2171695A (en) 1996-01-04
TW496740B (en) 2002-08-01
CA2152023A1 (en) 1995-12-18
AU697136B2 (en) 1998-09-24
HU9501779D0 (en) 1995-08-28
NO952411D0 (no) 1995-06-16
JPH083058A (ja) 1996-01-09
NO952411L (no) 1995-12-18
EP0687470A3 (en) 1996-06-19

Similar Documents

Publication Publication Date Title
IL121170A0 (en) Compositions for the treatment of dermatological disorders
PT861081E (pt) Utilizacao de epinastina para o tratamento de dores
PT966436E (pt) Arilsulfonamidas e analogos e sua aplicacao para o tratamento de doencas neurodegenerativas
NO976063D0 (no) Fremgangsmåte for behandling av diabetes
DK0769017T3 (da) Terapeutiske forbindelser
FI972584A0 (fi) Substituoituja atsetidin-2-oneja ateroskleroosin hoitamiseksi
NO963785D0 (no) Fremgangsmåte for behandling av 5HT2B-reseptor-relaterte betingelser
IL118289A0 (en) The use of glyceryl triacetate for treatment of onychomycoses
NO20012106L (no) Middel for behandling av forstyrrelser i benmetabolismen
ID23175A (id) Penggunaan benzopiranol untuk mengobati gangguan syaraf
FI952953A (fi) Aineita metabolisten luustosairauksien hoitamiseen
NO974569L (no) Benzamider for behandling av neurodegenerative forstyrrelser
NO982562D0 (no) Sammensetning for behandling av smerte
BR9608595A (pt) Utilização de n-cicloexil benzamidas para o tratamento de aglições intestinais
ATE235494T1 (de) Imino-aza-anthracyclonderivate zur behandlung von amyloidosis
EP0755262A4 (en) PNEUMOPATHY TREATMENT COMPOSITION
KR960700729A (ko) 26,26,26,27,27,27-헥사플루오로-1 알파, 25-디히드록시콜레칼시페롤의 칼슘 대사 장애의 치료 용도(Use of 26,26,26,27,27,27-Hexafluoro-1alpha, 25-Dihydroxycholecalciferol for the treatment of Calcium Metabolism Disorders)
NO962812D0 (no) Fremgangsmåte for behandling av nervebetennelse
FI970269A0 (fi) 1,3-diolipohjaisten esterien seokset, menetelmä 1,3-diolipohjaisten esterien valmistamiseksi sekä esterien käyttö
MD281F1 (ro) Masajor magnetodinamic
KR960019736U (ko) 구두바닥의 구조
KR970020846U (ko) 근골격계질환 치료보조용 반창고
KR950032251U (ko) 사우나용 찜질방 구조
FI940614A0 (fi) Foerfarande foer framstaellning av jordfoerbaettringsaemnet
FI944868A0 (fi) Foerfarande foer foerbaettring av en braennare